Case Studies

Branding and Public Relations for a Publicly Traded Biotech company


As a team of seasoned public relations and marketing professionals, we had the privilege of providing our services to Longeveron, a publicly traded biotech company on the Nasdaq. A global leader in stem cell therapies that was founded in 2014, Longeveron’s mission is to deliver regenerative medical therapies for unmet medical needs. As a clinical-stage biotech company dedicated to developing cellular therapies for aging-related and life-threatening conditions, Longeveron hypothesizes that stem cells might reduce the difficulties associated with aging and offer improved quality of life for patients with life-threatening conditions.

TriVision’s partnership with the Miami-based biotech company began in 2021 when they selected us to rebrand their company and lead a comprehensive public relations campaign. Our role was to oversee an outreach and communication campaign with the investor community, financial media, and mainstream media. As the company continued to grow, they also asked us to refresh their brand identity and build their new comprehensive website which we maintain until today.



Through a focused media strategy and PR campaign, TriVision was able to help the company achieve its goals in creating buzz and brand awareness to earn the media attention it deserves. With our efforts in drafting press releases, writing thought leadership pieces, and securing media interviews for Longeveron executives, we were able to contribute to a dramatic increase in the company’s share price in the fall of 2021. Our creative designers and web team also succeeded in revitalizing the brand and website in a way that made a noticeable impact.

TriVision is honored to work closely with Longeveron as their PR and marketing company in advancing their mission and vision of breakthrough biotechnology.


Scroll to Top